Become A Featured Company

Tidal Royalty strikes deal with MichiCann to launch new U.S. cannabis player

Ryan Allway

February 14th, 2019

News

Tidal Royalty Inc. (RLTYu.CD) signed a letter of intent to merge with MichiCann Medical Inc., a privately-held cannabis retailer and producer, in a deal that would create a major U.S. multi-state operator worth an estimated US$800 million.

The deal, to be announced Thursday morning, will combine Toronto-based Tidal Royalty’s cannabis portfolio assets in several U.S. states, including Massachusetts and California, with those of MichiCann, which operates in Michigan under the Red White & Bloom trade name.

MichiCann owns or controls 11 medical cannabis dispensaries in Michigan and is in the final stages to acquire another 11 shops, as well as three indoor cultivation facilities in the state, according to MichiCann Medical CEO Brad Rogers, who will be the new chief executive of the combined companies.

“Our acumen in selling cannabis is second to none,” Rogers said in a phone interview with BNN Bloomberg. “We’re looking to build and scale an operation not just in Michigan but throughout the United States.”

To complete the merger, Tidal Royalty, which is currently listed on the Canadian Securities Exchange, will consolidate its issued and outstanding shares on an 8:1 basis, Rogers said. He added Tidal will then issue 2.08 of its consolidated shares for every one of MichiCann shares. MichiCann shareholders will own 80 per cent of the combined company, which will take on the Red White & Bloom moniker, while Tidal will own the remaining 20 per cent.

“When we first starting talking about this deal, the revenue opportunities that MichiCann brings to the table just made sense,” said Theo Van Der Linde, the chief financial officer of Tidal Royalty, in a phone interview with BNN Bloomberg. “This is a very dynamic market and the royalty model we used worked in Canada for a while, but in the U.S., it didn’t seem like the market was paying attention to it.”

The merger also marks the first major deal under Rogers’ tutelage after he left CannTrust Holdings Inc. as the company’s president in November. Prior to Rogers’ tenure at CannTrust, he was the co-founder of Mettrum Health Corp. which was acquired by Canopy Growth Corp. in December 2016 for $430 million in stock.

“[MichiCann] has been in stealth mode for a while,” said Rogers. “This one is going to be bigger, better, badder than my old ventures.”

Tidal will halt trading on its shares on the CSE until the companies close the transaction, Rogers said. The new company will look to privately raise US$75 million to US$100 million with Canadian merchant banks at a valuation of US$800 million to US$900 million before re-listing on the CSE within the next 60 days.

Paul Rosen, the CEO of Tidal Royalty, will see his role redefined in the combined company, Rogers said. Rosen wasn’t immediately available for comment.

Going forward, Red White & Bloom will focus on the Michigan, California, Massachusetts and Florida medicinal markets ahead of what Rogers expects to be a flurry of states that will legalize recreational marijuana. At the end of the year, Red White & Bloom will operate in states that will account for 75 per cent of cannabis consumption in the U.S., Rogers added.

The company will also compete with a number of other major so-called vertically-integrated cannabis companies that produce, distribute and sell their marijuana in the U.S. states they are licensed in. While the U.S. market will likely remain fragmented due to federal laws and regulations, the country is able to handle between 10 to 12 multi-state operators competing for cannabis consumers, said Hadley Ford, CEO of iAnthus Capital Holdings Inc., in a recent interview with BNN Bloomberg.

Michigan, which has the highest per capita usage of cannabis in the U.S., regulated its medical marijuana program in October. The state brought in US$30.2 million in its first four months of sales, according to the state’s Bureau of Marijuana Regulation. Nearly 3,000 kilograms of medical marijuana were sold from October 2018 to Feb. 4, according to the bureau.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading